Evaxion announces business update and first quarter 2024 financial results

Copenhagen, denmark, may 28, 2024 (globe newswire) -- evaxion biotech a/s (nasdaq: evax) ("evaxion" or the "company"), a clinical-stage techbio company specializing in developing ai-immunology™ powered vaccines, provides business update and announces first quarter 2024 financial results.
EVAX Ratings Summary
EVAX Quant Ranking